A perspective on African American participation in clinical trials

Contemporary Clinical Trials

Volumn 28, Issue 2, 2007, Pages 213-217

  Shaya, Fadia T ^a   Gbarayor, Confidence M ^a   Huiwen Keri Yang, ^a   Agyeman Duah, Marriette ^a   Saunders, Elijah ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; Clinical trials; Collaborative Care Model; Enrollment; Health outcomes; Healthcare disparities; Minorities; Minority investigators; Recruitment

Indexed keywords

AFRICAN AMERICAN; ARTICLE; AUTHORITY; HUMAN; PATIENT PARTICIPATION; PHYSICIAN;

EID: 33845596884     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2006.10.001     Document Type: Note

References (28)

1. Department of Health and Human Services (US). Healthy people 2010: understanding and improving health. 2nd ed. (Nov 2000), DHHS, Washington
2. Hall PS., Hill MN., Roary MC., Post W.S., and Blumenthal R.S. A look at hypertension in young African-American men. Nurse Pract 28 1 (Jan. 2003) 59-60
3. Chandra A., and Paul D.P. African American participation in clinical trials: recruitment difficulties and potential remedies. Hosp Top 81 2 (Spring 2003) 33-38
4. Powell J.H., and Fleming Y. Making medicines for America: the case for clinical trial diversity. J Natl Med Assoc 92 11 (Nov 2000) 507-514
5. Wu E., El-Bassel N., Witte S.S., Gilbert L., Chang M., and Morse P. Enrollment of minority women and their main sexual partners in an HIV/STI prevention trial. AIDS Educ Prev 17 1 (2005) 41-52
6. DiClemente R.J., Wingood G.M., Harrington K.F., et al. Efficacy of an HIV prevention intervention for African American adolescent girls: a randomized controlled trial. JAMA 292 2 (2004) 171-179
7. Winkleby MA., Kraemer HC., Ahn DK., and Varady A.N. Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 280 4 (Nov 1998) 356-362
8. Ferdinand K.C. Coronary heart disease and lipid-modifying treatment in African American patients. Am Heart J 147 5 (May 2004) 774-782
9. Alter M.J., Kruszon-Moran D., and Nainan O.V. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341 (1999) 556-562
10. Pyrsopoulos N., and Jeffers L. Chronic hepatitis C in African Americans. Clin Liver Dis 9 3 (2005) 427-438 [vii]
11. Gifford A.L., Cunningham W.E., Heslin K.C., et al. HIV cost and services utilization study consortium. Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med 346 18 (2002) 1373-1382
12. Taylor A.L., Ziesche S., Yancy C., et al., African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 20 (Nov 11 2004) 2049-2057
13. Agodoa L.Y., Appel L., Bakris G.L., et al., African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 285 21 (Jun 6 2001) 2719-2728
14. Abbott K.C., and Bakris G.L. What have we learned from the current trials?. Med Clin North Am 88 1 (Jan 2004) 189-207
15. King T.E., and Wheeler M.B. Inequity in health care: unjust, inhumane, and unattended!. Ann Intern Med 141 (2004) 815-817
16. Bach P.B., Schrag D., Brawley O.W., Galaznik A., Yakren S., and Begg C.B. Survival of blacks and whites after a cancer diagnosis. JAMA 287 16 (2002) 2106-2113
17. [No authors listed]. Recommendations of the clinical trials consensus panel. National Medical Association. J Natl Med Assoc 92 10 (Oct 2000) 464-471
18. Freedman T.G. "Why don't they come to Pike Street and ask us"?: Black American women's health concerns. Soc Sci Med 47 7 (1998) 941-947
19. Robinson S.B., Ashley M., and Haynes M.A. Attitude of African-Americans regarding prostate cancer clinical trials. J Commun Health 21 2 (1996) 77-87
20. Long J.A., Chang V.W., Ibrahim S.A., and Asch D.A. Update on the health disparities literature. Ann Intern Med 141 10 (2004) 805-812
21. Harris Y., Gorelick P.B., Samuels P., and Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc 88 10 (Oct 1996) 630-634
22. Shavers V.L., Lynch C.F., and Burmeister L.F. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol 12 4 (2002) 248-256
23. Simon M.S., Du W., Flaherty L., et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 22 11 (2004) 2046-2052
24. Shaya F.T., and Blume S. Prescription for cyclooxygenase-2 inhibitor and other non-steroidal anti-inflammatory agents in a medicaid managed population: African Americans versus Caucasians. Pain Med 6 1 (2005) 11-17
25. King T.E., and Wheeler M.B. Inequity in health care: unjust, inhumane, and unattended!. Ann Intern Med 141 (2004) 815-817
26. KB Drennan."Recruitment and retention: what works and why" Increasing Diversity in Clinical Trials: Best Practices, Health Disparities Symposium, October 2, 2003. Accessed on: http://www.niaid.nih.gov/healthdisparities/HDSYMPOSIUM/proceedings2/recruitment.htm.
27. Corbie-Smith G., Moody-Ayers S., and Thrasher A.D. Closing the circle between minority inclusion in research and health disparities. Arch Intern Med 164 13 (Jul 2004) 1362-1364
28. Cohen J.J. "Closing the gaps by working together". Presented at the Association of American Medical Colleges annual meeting, October 24, 1999. Washington, DC. Available at: http://www.aamc.org/newsroom/speeches/99amspee.htm. Accessed June 25, 2006.